Skip to content
Catalyst

PapersPMID:34323337

The effect of an orally-dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: A double-blind, randomised, placebo-controlled study.

Journal of human nutrition and dietetics2022The record ↗

findings
3
compound
1
endpoints
3
PMID:34323337
  1. Finding, moderate evidencelowersFat mass
  2. Finding, moderate evidencelowersBody mass
  3. Finding, moderate evidencelowersBody mass index
Study, every finding
RCT · 4 months
Dose studied, every finding
450 mg per day across two 225 mg capsules, one at breakfast and one at dinner
  • “After 16 weeks of treatment, the Gpp group had a significant reduction in total body weight, BMI, total fat mass and gynoid fat mass compared to the placebo group (p < 0.05) (Figure and Table 2).”
    • Interests
      Industry funded
      Population
      Overweight and class one obese men and women over 18 years (BMI over 25 to under 35 kg/m2); total body fat by dual-energy X-ray absorptiometry; placebo was maltodextrin in identical capsules
    • Interests
      Industry funded
      Population
      Overweight and class one obese men and women over 18 years (BMI over 25 to under 35 kg/m2); placebo was maltodextrin in identical capsules
    • Interests
      Industry funded
      Population
      Overweight and class one obese men and women over 18 years (BMI over 25 to under 35 kg/m2); placebo was maltodextrin in identical capsules

Study record

Design
randomised controlled trial
Species
human
Population
Overweight and class one obese men and women over 18 years, Brisbane Australia; ActivAMP G. pentaphyllum capsule supplement
Participants
150
Comparator
placebo
Duration
112 days
Endpoints measured
31